Citation Impact
Citing Papers
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
2013 Standout
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
2006
A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation
2006
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Mechanisms of Thrombus Formation
2008 Standout
International Union of Pharmacology. XLIX. Nomenclature and Structure-Function Relationships of Transient Receptor Potential Channels
2005 StandoutNobel
Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel
2007
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
High Residual Platelet Reactivity After Clopidogrel Loading and Long-term Cardiovascular Events Among Patients With Acute Coronary Syndromes Undergoing PCI
2011
Large early variation of residual platelet reactivity in Acute Coronary Syndrome patients treated with clopidogrel
2015 StandoutNobel
Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFkB
2010
Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis
2009
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)
2006
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
2007
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
2010
Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
2007
Dietary Magnesium Intake in a National Sample of U.S. Adults
2003
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin
2006
Variability in Individual Responsiveness to Clopidogrel
2007
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Magnesium and depression: a systematic review
2013
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser
2012
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
2008
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
2013 Standout
Magnesium causes nitric oxide independent coronary artery vasodilation in humans
2001
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
2007
Exercise Standards for Testing and Training
2013 Standout
Relationship Between Exposure to Prasugrel Active Metabolite and Clinical Outcomes in the TRITON‐TIMI 38 Substudy
2011
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Magnesium Intake and Risk of Coronary Heart Disease among Men
2004
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
The Year in Non-ST-Segment Elevation Acute Coronary Syndromes
2005
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial
2008
Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients
2013 StandoutNobel
Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
2010
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro
2004
Antithrombotic Therapy for VTE Disease
2012 Standout
Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis
2013
Role of Prasugrel, a Novel P2Y12 Receptor Antagonist, in the Management of Acute Coronary Syndromes
2009
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Endothelial Dysfunction, Arterial Stiffness, and Heart Failure
2012
DNA Damage, Aging, and Cancer
2009 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Magnesium in disease
2012
Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel
2006
Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women
2007
A randomized study of intravenous magnesium in acute myocardial infarction treated with direct coronary angioplasty
2000
Pharmacology of Antiplatelet Agents
2013
Determinants of the interindividual variability in response to antiplatelet drugs
2005
High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy
2013
Effects of a Randomized Controlled Trial of Transcendental Meditation on Components of the Metabolic Syndrome in Subjects With Coronary Heart Disease
2006
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Role of Magnesium in Reducing Mortality in Acute Myocardial Infarction
1993
Impact of reduced insulin‐like growth factor‐1/insulin signaling on aging in mammals: novel findings
2008
Prevention of Venous Thromboembolism
2004 Standout
Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling
2002
Major Pulmonary Embolism
2002
Guidelines for Percutaneous Coronary Interventions
2005
Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent Placement
2006
Effect of modulating the allosteric sites of N-methyl-D-aspartate receptors in ischemia-reperfusion induced acute kidney injury
2013
Aspirin and Antiplatelet Agent Resistance
2010
Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)
1992
Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
2008 Standout
Secondary prevention with folic acid: effects on clinical outcomes
2003
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
2008
Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
2009
Clopidogrel Loading Dose (300 Versus 600 mg) Strategies for Patients With Stable Angina Pectoris Subjected to Percutaneous Coronary Intervention
2006
Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease
2006
Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis
2008
Myocardial Reperfusion Injury
2007 Standout
Magnesium in CKD: more than a calcification inhibitor?
2014
Impaired vascular function in patients with Fontan circulation
2006
Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation
2006
Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
2009
Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis
2005
Clopidogrel 150 mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention
2008
Current Options in Platelet Function Testing
2006
Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials
2008
Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis
2007
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects
2008
Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies
2013
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies
1996
High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome
2005
Can Meditation Slow Rate of Cellular Aging? Cognitive Stress, Mindfulness, and Telomeres
2009 StandoutNobel
Antiplatelet treatment for coronary heart disease
2005
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Muscle cramps and magnesium deficiency: case reports.
1996
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
2011
Patterned Hydrogels for Controlled Platelet Adhesion from Whole Blood and Plasma
2010 StandoutNobel
Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y 12 Antagonist, With Clopidogrel in Percutaneous Coronary Intervention
2005
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Platelet Function Testing in Cardiovascular Diseases
2004
Contribution of Gene Sequence Variations of the Hepatic Cytochrome P450 3A4 Enzyme to Variability in Individual Responsiveness to Clopidogrel
2006
Magnesium in Man: Implications for Health and Disease
2014 Standout
Distribution of ankle—brachial index and the risk factors of peripheral artery disease in a multi-ethnic Asian population
2011
Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association
2016
Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes
2007
Regulation of magnesium content during proliferation of mammary epithelial cells (HC-11)
2004
Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies
2010
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Aging and vascular endothelial function in humans
2011
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Venous Thromboembolism
1989
2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
2014
Role of Clopidogrel in Managing Atherothrombotic Cardiovascular Disease
2007
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
2006 Standout
Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets
2005
Intravenous magnesium for acute myocardial infarction
2007
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
Coronary Microembolization
2009
Aspirin and Antiplatelet Agent Resistance
2010
Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation
2010
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
2007
TRPM7: Channeling the Future of Cellular Magnesium Homeostasis?
2004
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
2011
2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
2014
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
2007
Part 8: Post–Cardiac Arrest Care
2015 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
2009
Magnesium Sulfate Reduces Myocardial Infarct Size When Administered Before but Not After Coronary Reperfusion in a Canine Model
1995
Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial
2002
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
2010
Comparative Antithrombotic Effects of Magnesium Sulfate and the Platelet Glycoprotein IIb/IIIa Inhibitors Tirofiban and Eptifibatide in a Canine Model of Stent Thrombosis
2002
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
2015
Monitoring of Clopidogrel Action: Comparison of Methods
2005
Clopidogrel Response Variability and Future Therapies
2006
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Regulation of cation channels in cardiac and smooth muscle cells by intracellular magnesium
2006
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Michael Shechter being referenced
Stress-induced ST-segment elevation in patients without prior Q-wave myocardial infarction
2008
Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease
2008
Long-Term Outcome of Intravenous Magnesium Therapy in Thrombolysis-Ineligible Acute Myocardial Infarction Patients
2003
Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy
1995
Safety and Efficacy of the FilterWire EZ in Acute ST-Segment Elevation Myocardial Infarction
2007
Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients
2006
Obese adults with primary growth hormone resistance (Laron Syndrome) have normal endothelial function
2007
Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease
1999
Does Magnesium Have a Role in the Treatment of Patients with Coronary Artery Disease?
2003
Peripheral Monocytosis following Acute Myocardial Infarction: Incidence and Its Possible Role as a Bedside Marker of the Extent of Cardiac Injury
1998
Beneficial effect of magnesium sulfate in acute myocardial infarction
1990
External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris
2003
Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure†
2009
Review of echocardiographically diagnosed right heart entrapment of pulmonary emboli-in-transit with emphasis on management
1987
Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction
2004
Magnesium and myocardial infarction.
2005
Magnesium and cardiovascular system.
2010
Pulse pressure is a predictor of vascular endothelial function in middle-aged subjects with no apparent heart disease
2010
Oral Magnesium Therapy Improves Endothelial Function in Patients With Coronary Artery Disease
2000
Intravenous Magnesium in Experimental Stent Thrombosis in Swine
2001
The Rationale of Magnesium Supplementation in Acute Myocardial Infarction
1992
The Assessment of Endothelial Function
2012